IVI and the Association of Southeast Asian Nations

 

Ongoing Collaboration 

 

Indonesia, Myanmar, the Philippines, Thailand, and Viet Nam are IVI Member States and host ongoing IVI programs. 

 

Cambodia, Laos, and Timor-Leste also host ongoing IVI programs, while Malaysia and Singapore have previously collaborated with IVI. 

 

Previous Collaboration

 

2025 ASEAN Vaccine Security and Self-Reliance (AVSSR) training program

In August 2025, IVI, Thailand’s National Vaccine Institute (NVI), and the World Bank organized a vaccine workforce development program for ASEAN countries at the Mandarin Hotel in Bangkok. The training program took place on the sidelines of the annual AVSSR meeting.

 

2024 ASEAN Vaccine Security and Self-Reliance (AVSSR) training program

In September 2024, IVI and Thailand’s National Vaccine Institute (NVI) hosted a two-day training program consisting of lectures, practical case studies, and interactive activities highlighting topics across vaccine technology transfer, from process development to business and legal implications; global regulatory practices, including experiences from pooled procurement initiatives; risk communication; and global health security coordination. 

 

Facilitating these sessions were speakers from IVI and NVI as well as key vaccine manufacturers in the region such as PT Bio Farma and SK bioscience; global coalitions such as the CEPI-hosted Regionalized Vaccine Manufacturing Collaborative; government agencies including the Korea Disease Control and Prevention Agency, and the Duke-NUS Centre of Regulatory Excellence.

 

ROK-Australia-ASEAN Vaccine Forum

On June 29, 2021, IVI, ASEAN, the Republic of Korea’s Ministry of Foreign Affairs, and Australia’s Department of Foreign Affairs and Trade, hosted the ROK-Australia-ASEAN Vaccine Forum to discuss cooperation for vaccine security and economic recovery from the COVID-19 pandemic.

 

The forum brought together more than 100 diplomats and public health officials from ASEAN member states, Australia, Korea, and the United States, as well as professionals and experts from the National Institute of Infectious Diseases of Korea, the National Vaccine Institute of Thailand, and the Centre for Virus Research of Australia.

 

Through presentations and panel discussions, the parties sought ways of cooperation including information-sharing, increased transparency, and easing of export restrictions to build a vaccine supply network which will allow for accelerated production and distribution of high-quality vaccines.